Clinical trials recruiting for Metastatic HER2-Negative Breast Carcinoma
7
Recruiting trials
44
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 6
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Washington | 4 |
| Arizona | 2 |
| Missouri | 2 |
| Tennessee | 2 |
| Alabama | 1 |
| Alaska | 1 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Delaware | 1 |
| Florida | 1 |
| Georgia | 1 |
Top cities
Seattle, Washington 4Nashville, Tennessee 2St Louis, Missouri 2Abilene, Texas 1Albuquerque, New Mexico 1Allentown, Pennsylvania 1Altoona, Pennsylvania 1Anaconda, Montana 1Anchorage, Alaska 1Ankeny, Iowa 1
Self-screener
Recruiting trials
- A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
- Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
- Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
- Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Related conditions
Trials recruiting for Metastatic HER2-Negative Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Anatomic Stage IV Breast Cancer AJCC v8 43Metastatic Hormone Receptor-Positive Breast Carcinoma 4Metastatic Malignant Solid Neoplasm 21Anatomic Stage III Breast Cancer AJCC v8 39Unresectable Malignant Solid Neoplasm 8Unresectable Lung Non-Small Cell Carcinoma 5Unresectable Cutaneous Melanoma 3Stage IV Lung Cancer AJCC v8 45Stage III Lung Cancer AJCC v8 22
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic HER2-Negative Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.